SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001521036-19-000007
Filing Date
2019-04-30
Accepted
2019-04-30 08:48:51
Documents
72
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q lnth10q-033119.htm 10-Q 895640
2 EXHIBIT 10.1 lnth10q-033119ex101.htm EX-10.1 12256
3 EXHIBIT 31.1 lnth10q-033119ex311.htm EX-31.1 14939
4 EXHIBIT 31.2 lnth10q-033119ex312.htm EX-31.2 15032
5 EXHIBIT 32.1 lnth10q-033119ex321.htm EX-32.1 13786
  Complete submission text file 0001521036-19-000007.txt   4175631

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT lnth-20190331.xml EX-101.INS 791923
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lnth-20190331.xsd EX-101.SCH 34662
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lnth-20190331_cal.xml EX-101.CAL 90355
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lnth-20190331_def.xml EX-101.DEF 71285
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lnth-20190331_lab.xml EX-101.LAB 407008
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lnth-20190331_pre.xml EX-101.PRE 234589
Mailing Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Business Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862 978 671-8001
Lantheus Holdings, Inc. (Filer) CIK: 0001521036 (see all company filings)

IRS No.: 352318913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36569 | Film No.: 19778700
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences